These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6070597)

  • 21. [Trials of vaccination against measles with live and attenuated virus].
    Albano A; De Donato S; Nodari R; Criscuolo A
    G Mal Infett Parassit; 1967 Oct; 19(10):631-8. PubMed ID: 5611500
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 23. Panel on immunizations.
    Fulginiti VA; Nelson JD; McCracken GH
    Pediatr Infect Dis; 1983; 2(3 Suppl):S64-9. PubMed ID: 6866802
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical serological study of combined inocculation of measles inactivated and raw vaccines. 2. KL in Kenkyukai and Arakawa inactivated vaccine and Matsumoto and Arakawa raw vaccine].
    Tanabe Y; Arai M
    Nihon Shonika Gakkai Zasshi; 1967 Apr; 71(4):425-8. PubMed ID: 6070358
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-measles vaccination with inactivated virus].
    Terragna A; Roscioli B; De Marco B
    G Mal Infett Parassit; 1967 Apr; 19(4):219-22. PubMed ID: 5614197
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical serological study of combined inocculation of measles inactivated and raw vaccines. 1. Effect of the inactivated vaccine].
    Tanabe Y; Nakamura M
    Nihon Shonika Gakkai Zasshi; 1967 Apr; 71(4):419-24. PubMed ID: 6070357
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the live AIK measles virus vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
    Kitasato Arch Exp Med; 1973 Dec; 46(3-4):83-92. PubMed ID: 4805362
    [No Abstract]   [Full Text] [Related]  

  • 28. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of moderate malnutrition on morbidity and antibody response following vaccination with live, attenuated measles virus vaccine.
    McMurray DN; Loomis SA; Casazza LJ; Rey H
    Bull Pan Am Health Organ; 1979; 13(1):52-7. PubMed ID: 427297
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical immunoserological study of combined innoculation of inactivated and live measles vaccines].
    Yamazaki Y
    Nihon Shonika Gakkai Zasshi; 1969 May; 73(5):644-55. PubMed ID: 5817193
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on immunity to measles. II. Prophylactic and serological studies on the use of live and attenuated measles-virus vaccine].
    Egami T
    Kumamoto Igakkai Zasshi; 1966 May; 40(5):539-62. PubMed ID: 4164172
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
    Sekiguchi H; Numazaki Y; Ikeda M; Yano N
    Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
    [No Abstract]   [Full Text] [Related]  

  • 34. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study on clinical reactions after inoculation of measles vaccine and transition of antibody values. 2. Clinical reactions with combination of inactivated raw vaccine and blood antibody value].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1968 Jan; 72(1):16-20. PubMed ID: 5691552
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions].
    Naruszewicz-Lesiuk D; Kańtoch M; Polna I
    Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunization practices and controversies 1981: Part 1-The "big seven" vaccines.
    Backes CR
    J Am Osteopath Assoc; 1981 May; 80(9):595-603. PubMed ID: 7251409
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.